neoplasm
• female mice treated with ENU survive for 86 days as compared to 66-71 days for mice carrying ApcMin alone
|
• female mice treated with ENU develop significantly fewer intestinal tumors than mice carrying either ApcMin alone or C57BL/6 controls
|
• female mice treated with ENU develop significantly fewer mammary tumors than mice carrying either ApcMin alone or C57BL/6 controls
|
• female mice treated with ENU develop significantly fewer mammary or intestinal tumors than mice carrying either ApcMin alone or C57BL/6 controls
|
homeostasis/metabolism
• female mice treated with ENU develop significantly fewer mammary or intestinal tumors than mice carrying either ApcMin alone or C57BL/6 controls
|
integument
• female mice treated with ENU develop significantly fewer mammary tumors than mice carrying either ApcMin alone or C57BL/6 controls
|
endocrine/exocrine glands
• female mice treated with ENU develop significantly fewer mammary tumors than mice carrying either ApcMin alone or C57BL/6 controls
|
digestive/alimentary system
• female mice treated with ENU develop significantly fewer intestinal tumors than mice carrying either ApcMin alone or C57BL/6 controls
|